Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

14.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time delays between fingerstick glucose measurements and correctional insulin administration in the hospital: do they really matter?

Diabetologia·2026
Same author

Understanding Glycemia in the Post Discharge Period Through Blinded Continuous Glucose Monitoring.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same author

Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same author

Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP Systems.

Journal of diabetes science and technology·2025
Same author

Early Stages of Automated Insulin Delivery.

Journal of diabetes science and technology·2025
Same author

Early Stages of Automated Insulin Delivery.

Diabetes technology & therapeutics·2025

Related Experiment Video

Updated: Feb 22, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.4K

Type 1 Diabetes - A Clinical Perspective.

Lindy Kahanovitz1,2, Patrick M Sluss3, Steven J Russell2

  • 1Department of Biotechnology Engineering, Ben Gurion University of the Negev, Beersheva, Israel.

Point of Care
|September 26, 2017
PubMed
Summary
This summary is machine-generated.

Type 1 diabetes results from autoimmune destruction of pancreatic beta-cells, causing insulin deficiency. Management focuses on controlling blood glucose using hemoglobin A1c and blood glucose level measurements for diagnosis and long-term care.

Keywords:
C-peptideType 1 diabetescontinuous glucose monitoringhemoglobin A1cinsulinpoint of careself monitoring blood glucose

More Related Videos

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

17.0K
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

10.1K

Related Experiment Videos

Last Updated: Feb 22, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.4K
Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

17.0K
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

10.1K

Area of Science:

  • Endocrinology
  • Immunology
  • Metabolic Diseases

Background:

  • Type 1 diabetes is an autoimmune condition characterized by the destruction of pancreatic beta-cells.
  • This destruction leads to an absolute deficiency of insulin, a critical hormone for glucose regulation.
  • Maintaining blood glucose within an acceptable range is the primary therapeutic objective.

Purpose of the Study:

  • To provide a concise overview of type 1 diabetes.
  • To describe the underlying pathophysiology of the disease.
  • To outline current diagnostic and management strategies.

Main Methods:

  • Review of the pathophysiology of autoimmune beta-cell destruction.
  • Description of diagnostic criteria and methods.
  • Summary of therapeutic approaches for blood glucose control.

Main Results:

  • Hemoglobin A1c and blood glucose levels are key indicators.
  • These measurements are essential for both initial diagnosis and ongoing disease management.
  • Effective management aims to prevent hyperglycemia and its complications.

Conclusions:

  • Type 1 diabetes requires lifelong management strategies.
  • Accurate diagnosis and consistent monitoring are crucial for patient outcomes.
  • Understanding the pathophysiology informs effective treatment protocols.